HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Twigg, H. L. Search for Related Content PubMed PubMed Citation Articles by Twigg, H. L., III

Humoral Immune Defense (Antibodies)

Recent Advances

Department of Medicine, Division of Pulmonary and Critical Care, Indiana University Medical Center, Indianapolis, Indiana

Correspondence and requests for reprints should be addressed to Homer L. Twigg III, M.D., Associate Professor of Medicine, Indiana University Medical Center, Richard Roudebush VA Medical Center, 1481 West 10th Street, VA 111P-IU, Indianapolis, IN 46202-2884. E-mail: htwig{at}iupui.edu

ABSTRACT

The humoral, or antibody, immune response is essential for host defense against bacterial pathogens. The lung has the ability to respond quickly to some pathogens through stimulation of resident antigen-specific memory B cells. Alternatively, after exposure to a new pathogen, the lung can generate de novo both a systemic and local (mucosal) antibody response. The resulting production of antigen-specific IgG and IgA act in concert to help clear the invading pathogen and reduce subsequent colonization of respiratory epithelium. Systemic vaccination against respiratory pathogens, although effective in generating systemic IgG responses and some mucosal IgA responses, may be less effective than vaccination through mucosal surfaces, which induce a brisk IgA and IgG response both locally and systemically depending on the site of antigen deposition. The local response is important in reducing colonization of the upper respiratory tract by pathogenic bacteria, the first step in the development of most causes of pneumonia. Future studies are needed to provide further insight on the site of pulmonary humoral host responses to bacterial challenge and optimal vaccine regimens to minimize the burden of respiratory disease caused by pathogenic bacteria.

Key Words: antibody • bacterial pneumonia • immunoglobulin • vaccine

This article has been cited by other articles:

				M. Medina, J. Villena, E. Vintini, E. M. Hebert, R. Raya, and S. Alvarez Nasal Immunization with Lactococcus lactis Expressing the Pneumococcal Protective Protein A Induces Protective Immunity in Mice Infect. Immun., June 1, 2008; 76(6): 2696 - 2705. [Abstract] [Full Text] [PDF]